The effects of residual neuromuscular blockade and volatile anesthetics on the control of ventilation

Anesthesia and Analgesia

Volumn 89, Issue 1, 1999, Pages 243-251

  Eriksson, Lars I ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ATRACURIUM; INHALATION ANESTHETIC AGENT; NEUROMUSCULAR BLOCKING AGENT; PANCURONIUM; TUBOCURARINE CHLORIDE; VECURONIUM;

CAROTID BODY CHEMORECEPTOR; DRUG EFFECT; HUMAN; HYPOXIA; LUNG VENTILATION; NEUROMUSCULAR BLOCKING; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANESTHETICS, INHALATION; ANIMALS; ANOXIA; HUMANS; NEUROMUSCULAR BLOCKING AGENTS; NEUROMUSCULAR JUNCTION; RESPIRATION; SPECIES SPECIFICITY;

EID: 0033009722     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199907000-00045     Document Type: Review

References (67)

1. Lunn JN, Hunter AR, Scott DB. Anesthesia-related surgical mortality. Anaesthesia 1983;38:1090-6.
2. Cooper AI, Leigh JM, Tring IC. Admission to the intensive care unit after complications of anaesthetic technique over ten years. Anaesthesia 1989;44:953-8.
3. Brodie BC. Experiments and observations on the different modes in which death is produced by certain vegetable poisons. Philosoph Trans R Soc 1811;101:194-5.
4. Donati F, Meistelman C, Plaus B. Vecuronium neuromuscular blockade at the diaphragm, the orbicularis oculi, and the adductor pollicis muscles. Anesthesiology 1990;73:870-5.
5. Isono S, Koichi T, Suigimori K, et al. Differential effects of vecuronium at the diaphragm and geniohyoid muscle in anesthetized dogs. Br J Anaesth 1992;68:339-42.
6. Lebrault C, Chauvin M, Guirimand F, Duvaldestain P. Relative potency of vecuronium on the diaphragm and the adductor pollicis. Br J Anaesth 1989;63:389-92.
7. D'Honneur G, Gall O, Gerard A, et al. Priming doses of atracurium and vecuronium depress swallowing in humans. Anesthesiology 1992;77:1070-3.
8. Wright PM, Caldwell JE, Miller RD. Onset and duration of rocuronium and succinylcholine at the adductor pollicis and laryngeal adductor muscles in anesthetized humans. Anesthesiology 1994;81:1110-5.
9. Gal TJ, Smith TC. Partial paralysis with d-tubocurarine and the ventilatory response to CO2: an example of respiratory sparing? Anesthesiology 1976;45:22-8.
10. Gal TJ, Goldberg SK. Relationship between respiratory muscle strength and vital capacity during partial curarization in awake subjects. Anesthesiology 1981;54:141-7.
11. Eriksson LI. Reduced hypoxic chemosensitivity in partially paralysed man: a new property of muscle relaxants? Acta Anaesthesiol Scand 1996;40:520-3.
12. Dupuis JY, Martin R, Tetreault JP. Clinical, electrical and mechanical correlations during recovery from neuromuscular blockade with vecuronium. Can J Anaesth 1990;37:192-7.
13. Bowman WC. Non-relaxant properties of neuromuscular blocking drugs. Br J Anaesth 1982;54:147-60.
14. Ali HH, Utting JE, Gray C. Stimulus frequency in the detection of neuromuscular block in humans. Br J Anaesth 1970;42:967-77.
15. Ali HH, Wilson RS, Savarese JJ, Kitz RJ. The effect of tubocurarine on indirect elicited train-of-four muscle responses and respiratory measurements in humans. Br J Anaesth 1975;47:570-4.
16. Pavlin EG, Holle RH, Schoene R. Recovery of airway protection compared with ventilation in human after paralysis with curare. Anesthesiology 1989;70:381-5.
17. Eriksson LI, Sundman E, Olsson R, et al. Functional assessment of the pharynx at rest and during swallowing in partially paralyzed humans. Anesthesiology 1997;87:1035-43.
18. Kopman AF, Yee PS, Neuman GG. Relationship of the train-of-four fade ratio to clinical signs and symptoms of residual paralysis in awake volunteers. Anesthesiology 1997;86:765-71.
19. Berg H, Viby-Mogensen J, Roed J, et al. Residual neuromuscular block is a risk factor for postoperative pulmonary complications. Acta Anaesthesiol Scand 1997;41:1095-103.
20. D'Honneur G, Lofaso F, Drummond GB, et al. Susceptibility to upper airway obstruction during partial neuromuscular block. Anesthesiology 1998;88:371-8.
21. Kopman AF. Surrogate endpoints and neuromuscular recovery. Anesthesiology 1997;87:1029-31.
22. Sundman E, Eriksson LI, Witt H, et al. Laryngeal penetration and aspiration in partially paralysed humans [abstract]. Acta Anaesthesiol Scand 1997;41:168.
23. Fitzgerald RS, Lahiri S. Reflex responses to chemoreceptor stimulation. In: Fishman AP, ed. Handbook of physiology: the respiratory system II. Bethesda, MD: American Physiological Society, 1986:313-62.
24. Hornbein TF. The relations between stimulus to chemoreceptors and their response. In: Torrance RW, ed. Arterial chemoreceptors. Oxford: Blackwell, 1968:65-78.
25. Biscoe TJ, Willshaw P. Stimulus-response relationships of the arterial chemoreceptors. In: Hornbein TF, ed. Regulation of breathing. Part I. New York: Marcel Dekker, 1981:341-5.
26. Ponte J, Sadler CL. Interaction between hypoxia, acetylcholine and dopamine in the carotid body of rabbit and cat. J Physiol (Lond) 1989;410:395-410.
27. Metz B. Release of acetylcholine from carotid body by hypoxia and hypoxia plus hypercarbia. Resp Physiol 1969;6:693-9.
28. Lundberg JM, Hökfelt T, Nilsson O, Terenius L. Peptides in the cat carotid body (glomus caroticum): VIP-, enkephalin-and substance-P-like immunoreactivity. Acta Physiol Scand 1979; 107:279-81.
29. Heymans CJF. The part played by vascular presso-and chemoreceptors in respiratory control. In: Nobel lectures: physiology or medicine (1922-1941). Amsterdam: Elsevier, 1965:460-81.
30. Fidone SJ, Gonzalez C. Initiation and control of chemoreceptor activity in the carotid body In: Fishman AP, ed. Handbook of physiology. Baltimore: Waverly, 1986:247-312.
31. Fitzgerald RS, Shirata M. Carotid body neurotransmission. In: Data PG, Acker H, Lahiri S, eds. Neurobiology and cell physiology of chemoreception. New York: Plenum, 1991:131-6.
32. Eyzaguirre C, Monti-Bloch L. Nicotinic and muscarinic reactive sites in mammalian glomus cells. Brain Res 1982;252:181-4.
33. Cuello AC, McQueen DS. Substance P: carotid body peptide. Neurosci Lett 1980;17:215-9.
34. Bisgaard GE, Mitchell RA, Herbert DA. Effect of dopamine, norepinephrine and 5-hydroxytryptamine on the carotid body of the dog. Brain Res 1991;546:211-6.
35. Eriksson LI, Lennmarken C, Wyon N, Johnson A. Attenuated ventilatory response to hypoxaemia at vecuronium-induced partial neuromuscular block. Acta Anaesthesiol Scand 1992;36: 710-5.
36. Eriksson LI, Sato M, Severinghaus JW. Effect of vecuronium-induced partial neuromuscular block on hypoxic ventilatory response. Anesthesiology 1993;78:693-9.
37. Wyon N, Eriksson LI, Yamamoto Y, Lindahl SGE. Vecuronium-induced depression of phrenic nerve activity during hypoxia in the rabbit. Anesth Analg 1996;82:1252-6.
38. Wyon N, Joensen H, Yamamoto Y, et al. Carotid body chemoreceptor function is impaired by vecuronium during hypoxia. Anesthesiology 1999;89:1471-9.
39. Nunn JF. Effects of anaesthesia on respiration. Br J Anaesth 1990;65:54-62.
40. Hickey RF, Severinghaus JW. Regulation of breathing: drug effects. In: Hornbein RF, ed. Regulation of breathing lung biology in health and disease. Part II. Vol 17. New York: Marcel Dekker, 1981:1251-312.
41. Knill RL, Gelb AW. Ventilatory responses to hypoxia and hypercapnia during halothane sedation and anesthesia in humans. Anesthesiology 1978;49:244-51.
42. Knill RL, Kieraszewicz HT, Dodgson BG, Clement JL. Chemical regulation of ventilation during isoflurane sedation and anaesthesia in humans. Can Anaesth Soc J 1983;30:607-14.
43. Gelb AW, Knill RL. Subanesthetic halothane: its effect on regulation of ventilation and relevance to the recovery room. Can Anaesth Soc J 1978;25:488-94.
44. Nunn JF. Respiratory aspects of anesthesia. In: Nunn JF, ed. Applied respiration physiology. 4th ed. Oxford: Butterworth-Heinemann, 1993:390-1.
45. Pavlin EG, Su JY. Cardiopulmonary pharmacology. In: Miller RD, ed. Anesthesia. 4th ed. New York: Churchill Livingstone, 1994:125-56.
46. Dahan A, van den Elsen MJLJ, Berkenbosch A, et al. Effects of subanesthetic halothane on the ventilatory responses to hypercapnia and acute hypoxia in healthy volunteers. Anesthesiology 1994;80:727-38.
47. van den Elsen MJLJ, Dahan A, Berkenbosch A, et al. Does subanesthetic isoflurane affect the ventilatory response to acute isocapnic hypoxia in healthy volunteers. Anesthesiology 1994; 81:860-7.
48. Temp JA, Henson LC, Ward DS. Does a subanesthetic concentration of isoflurane blunt the ventilatory response to hypoxia? Anesthesiology 1992;77:1116-24.
49. Temp JA, Henson LC, Ward DS. Effects of a subanesthetic minimum alveolar concentration of isoflurane on two tests of the hypoxic ventilatory response. Anesthesiology 1994;80:739-50.
50. Sjögren D, Lindahl SGE, Sollevi A. Ventilatory responses to acute and sustained hypoxia during isoflurane anesthesia. Anesth Analg 1998;86:403-9.
51. Sjögren D, Sollevi A, Ebberyd A, Lindahl SGE. Isoflurane anesthesia (0.6 MAC) and hypoxic ventilatory responses in humans. Acta Anaesthesiol Scand 1995;39:17-22.
52. Sollevi A, Lindahl SGE. Hypoxic and hypercapnic ventilatory responses during isoflurane sedation and anaesthesia in women. Acta Anaesthesiol Scand 1995;39:931-8.
53. Robotham JL. Do low-dose inhalational anesthetic agents alter ventilatory control? Anesthesiology 1994;80:723-6.
54. Goodman NW. Volatile agents and the ventilatory response to hypoxia. Br J Anaesth 1994;72:503-5.
55. Young CH, Drummond GB, Warren PM. Effects of a subanaesthetic concentration of halothane on the ventilatory response to sustained hypoxia in healthy humans. Br J Anaesth 1993;71:642-7.
56. de Goede J, Berkenbosch A, Ward DS, et al. Comparison of chemoreceptor gains obtained with two different methods in cats. J Appl Physiol 1985;62:448-56.
57. Stuth EA, Tonkovic-Capin M, Kampine JP, et al. Dose-dependent effects of halothane on the carbon dioxide responses of expiratory and inspiratory bulbospinal neurons and the phrenic nerve activities in dogs. Anesthesiology 1994;81:1470-83.
58. Stuth EA, Tonkoics-Capin M, Kampine JP, Zuperku EJ. Dose-dependent effects of isoflurane on the CO2 responses of excitatory medullary neurons and the phrenic nerve activities in dogs. Anesthesiology 1992;76:763-74.
59. Stuth EA, Dogas Z, Krolo M, et al. Dose dependent effects of halothane on the phrenic nerve responses to acute hypoxia in vagotomized dogs. Anesthesiology 1997;87:1428-39.
60. Dahan A, Sarton E, van den Elsen MJLJ, et al. Ventilatory responses to hypoxia in humans: influences of subanesthetic desflurane. Anesthesiology 1996;85:60-8.
61. Koh SO, Severinghaus JW. Effects of halothane on hypoxic and hypercapnic ventilatory responses of goats. Br J Anaesth 1990; 65:713-7.
62. van Dissel JT, Berkenbosch A, Olievier CN, et al. Effects of halothane on the ventilatory response to hypoxia and hypercapnia in cats. Anesthesiology 1985;62:448-56.
63. Gaudy JH, Sicard JF, Maneglia R, Quignon M. Effets de l'halothane sur les gaz du sang et l'èquilibre acidobasique artériels chez le rat intact et chez le rat chernodenerve. Can Anaesth Soc J 1993;40:883-90.
64. Biscoe TJ, Millar RA. Effects of inhalation anesthetics on carotid body chemoreceptor activity. Br J Anaesth 1968;40:2-12.
65. Davies RO, Edwards MW, Lahiri S. Halothane depresses the response of carotid body chemoreceptors to hypoxia and hypercapnia in the rat. Anesthesiology 1982;57:153-9.
66. Ponte J, Sadler CL. Effects of halothane, enflurane and isoflurane on carotid body chemoreceptor activity in the rabbit and the cat. Br J Anaesth 1989;62:33-40.
67. Joensen H, Eriksson LI, Wyon N, Lindahl SGE. The effect of isoflurane on peripheral chemoreceptor sensitivity to varying PO2 and PCO2 [abstract]. Acta Anaesthesiol Scand 1997;39:152.